Cluster randomised triAl of PSA testing for Prostate cancer
- Conditions
- Prostate cancerCancerMalignant neoplasm of prostate
- Registration Number
- ISRCTN92187251
- Lead Sponsor
- niversity of Bristol (UK)
- Brief Summary
2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18156520 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19299260 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21047592 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21481132 results 2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23734773 results 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/24867688 results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25613468 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27130167 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27737692 results 2018 Results article in http://www.ncbi.nlm.nih.gov/pubmed/29509864 results
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 416000
Current inclusion criteria as of 06/08/2014:
All men aged 50 - 69 years from 573 GP practices in eight UK centres (Sheffield, Newcastle, Bristol, Birmingham, Cardiff, Leeds, Cambridge, Leicester). An additional centre, Edinburgh, where routine data on cause of death did not undergo validation, will be included in a secondary analysis.
Previous inclusion criteria:
All men aged 50 - 69 years from approximately 400 GP practices in nine UK centres (Sheffield, Newcastle, Bristol, Birmingham, Cardiff, Edinburgh, Leeds, Cambridge, Leicester)
Current exclusion criteria as of 06/08/2014:
Inclusion criteria not met. Men identified as already having a prostate cancer diagnosis.
Previous exclusion criteria:
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method